Suppr超能文献

哪些糖尿病患者应接受足病治疗?一项客观分析。

Which diabetic patients should receive podiatry care? An objective analysis.

作者信息

McGill M, Molyneaux L, Yue D K

机构信息

Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

出版信息

Intern Med J. 2005 Aug;35(8):451-6. doi: 10.1111/j.1445-5994.2005.00880.x.

Abstract

INTRODUCTION

Diabetes is the leading cause of lower limb amputation in Australia. However, due to limited resources, it is not feasible for everyone with diabetes to access podiatry care, and some objective guidelines of who should receive podiatry is required.

METHODS

A total of 250 patients with neuropathy (Biothesiometer; Biomedical Instruments, Newbury, Ohio, USA) ( > 30, age < 65)) but no active foot lesion, and 222 without neuropathy matched for age, type of diabetes, gender and duration, was followed prospectively for 2 years. Sensation was also tested using a 10 g Semmes Weinstein monofilament (Royal Prince Alfred Hospital Diabetes Centre). After the baseline examination, patients were contacted at 6 months and thereafter yearly to determine ulcer status. Incidence of foot ulceration across different risk categories was calculated using Kaplan-Meier survival curve. Log-rank test and Cox's proportional model were used to compare groups. The Number Needed to Treat (NNT) to prevent one ulcer per year was calculated using the standard formulae.

RESULTS

During the follow-up period, 34 new ulcers occurred in the neuropathy group and three ulcers in the control group (chi2 (1df) = 21.3; P < 0.0001), equating to an annual incidence of 6.3% and 0.5%, respectively. Fifty-four per cent of the ulcers were due to trauma from footwear. Further stratification of the neuropathy group showed annual incidence of ulceration to be 4% for those with abnormal biothesiometer reading, but who could still feel the monofilament, 10% for those who cannot feel the monofilament and 26% for those with previous ulceration or amputation. Predictors of ulceration were past history of ulceration/amputation (chi2 = 27.8; P < 0.0001) and the presence of neuropathy (chi2 = 4.7; P = 0.03). Assuming a 55% relative risk reduction in ulceration from podiatry care (mean of estimates from 10 reports), the NNT to prevent one foot ulcer per year was: no neuropathy (vibration perception threshold (VPT) < 30)), NNT = 367; neuropathy (VPT > 30) alone, NNT = 45; +cannot feel monofilament, NNT = 18; +previous ulcer/amputation, NNT = 7.

CONCLUSION

Provision of podiatry care to diabetic patients should not be only economically based, but should also be directed to those with reduced sensation, especially where there is a previous history of ulceration or amputation.

摘要

引言

在澳大利亚,糖尿病是下肢截肢的主要原因。然而,由于资源有限,让每个糖尿病患者都能获得足病治疗并不可行,因此需要一些关于谁应该接受足病治疗的客观指导原则。

方法

前瞻性随访了总共250例患有神经病变(使用生物感觉测量仪;美国俄亥俄州纽伯里的生物医学仪器公司)(>30,年龄<65岁)但无活动性足部病变的患者,以及222例年龄、糖尿病类型、性别和病程相匹配的无神经病变患者,为期2年。还使用10克Semmes Weinstein单丝(皇家阿尔弗雷德王子医院糖尿病中心)测试了感觉。在基线检查后,每6个月联系患者一次,此后每年联系一次以确定溃疡状态。使用Kaplan-Meier生存曲线计算不同风险类别中足部溃疡的发生率。使用对数秩检验和Cox比例模型比较各组。使用标准公式计算每年预防一例溃疡所需的治疗人数(NNT)。

结果

在随访期间,神经病变组出现34例新溃疡,对照组出现3例溃疡(卡方检验(1自由度)=21.3;P<0.0001),年发病率分别为6.3%和0.5%。54%的溃疡是由鞋类造成的创伤引起的。神经病变组的进一步分层显示,生物感觉测量仪读数异常但仍能感觉到单丝的患者溃疡年发病率为4%,不能感觉到单丝的患者为10%,有既往溃疡或截肢史的患者为26%。溃疡的预测因素是既往溃疡/截肢史(卡方检验=27.8;P<0.0001)和神经病变的存在(卡方检验=4.7;P=0.03)。假设足病治疗可使溃疡相对风险降低55%(10份报告估计值的平均值),每年预防一例足部溃疡所需的治疗人数为:无神经病变(振动感觉阈值(VPT)<30)),NNT=367;仅神经病变(VPT>30),NNT=45;+不能感觉到单丝,NNT=18;+既往溃疡/截肢史,NNT=7。

结论

为糖尿病患者提供足病治疗不应仅基于经济因素,还应针对感觉减退的患者,尤其是有既往溃疡或截肢史的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验